The use of adiponectin, a hormone derived from fat cells, which is abundant in plasma and easy to measure through commercially available kits, was confirmed as a robust biomarker predictive of glycemic efficacy in Type 2 diabetes and healthy subjects, after treatment with peroxisome proliferator-activated receptor-agonists (PPAR), but not after treatment with non-PPAR drugs such as metformin.
The 2009 mHealth (Mobile Health) Summit, organized by the Foundation for the National Institutes of Health (FNIH), today opens an unprecedented two-day summit bringing together more than 800 public and private sector science, medical, policy and mobile technology experts to develop a new roadmap related to the integration of science and wireless solutions to improve public health delivery, particularly to underserved populations, in the U.S. and around theworld.
he Boo! Run for Life 10K today announced that it has teamed up with anchor and managing editor of E! News Giuliana Rancic, and television host, speaker, and entrepreneur Bill Rancic in support of renal cell (or kidney) cancer research.
Today, the Foundation for the National Institutes of Health and sanofi-aventis announced an unprecedented donation by the global pharmaceutical leader providing approximately $1.3 million in pharmaceutical therapies for ongoing use in clinical trials and other therapeutic treatments at the National Institutes of Health (NIH)